Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) low breast cancer was considered as a distinct subtype different from HER2-zero breast cancer. Our study aimed to investigate the prognostic values of clinicopathological features and recurrence score (RS) in HER2-low and HER2-zero hormone...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mengdi, Chen, Weilin, Liu, Deyue, Chen, Weiguo, Shen, Kunwei, Wu, Jiayi, Zhu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385837/
https://www.ncbi.nlm.nih.gov/pubmed/35729304
http://dx.doi.org/10.1007/s12282-022-01364-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385837/
https://www.ncbi.nlm.nih.gov/pubmed/35729304
http://dx.doi.org/10.1007/s12282-022-01364-y

Ejemplares similares